Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5658 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 ... 55 56 57  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
RSP Systems–SEVERAL: investment, 201809 financing round Series B 2nd closing €3.85m incl new investor Trumpf Venture GmbH 2018-09-10
RSP Systems–Trumpf: investment, 201809 financing round Series B 2nd closing totalling €3.85m incl new investor Trumpf Venture GmbH 2018-09-10
Menarini–Lunaphore: staining technology, 201809– collab Menarini Diagnostics to market LabSat Frozen tissue staining solution 2018-09-09
Celgene–Evotec: drug discovery services, 201809– strategic RnD collab in field of targeted protein degradation using Panomics platform 2018-09-06
Novartis–Aurobindo: investment, 201809 acquisition $900m cash + $100m milestones of Sandoz US dermatology + oral generics businesses by Aurobindo USA 2018-09-06
Polyphor–Novo Group: investment, 201809 capital increase CHF6.8m with 179k shares at CHF38/share sold to Novo REPAIR Impact Fund 2018-09-06
Polyphor–Novo Group: investment, 201809– project-based + royalty-bearing investment up to CHF4.7m based on milestones in OMPTA program by Novo REPAIR 2018-09-06
Twentyeight-Seven–Astellas: investment, 201809 financing round Series A totalling $65m incl co-investor Astellas Venture Management 2018-09-06
Twentyeight-Seven–JnJ: investment, 201809 financing round Series A totalling $65m incl co-investor JnJ Innovation JJDC Inc 2018-09-06
Twentyeight-Seven–Longwood Fund: investment, 201809 financing round Series A totalling $65m incl co-investor Longwood Fund 2018-09-06
Twentyeight-Seven–MPM Capital: investment, 201809 financing round Series A totalling $65m incl founding + co-lead investor MPM Capital 2018-09-06
Twentyeight-Seven–Novartis: investment, 201809 financing round Series A totalling $65m incl co-lead investor NVF 2018-09-06
Twentyeight-Seven–SEVERAL: investment, 201809 financing round Series A $65m co-led by founding investor MPM Capital + NVF 2018-09-06
Twentyeight-Seven–Temasek: investment, 201809 financing round Series A totalling $65m incl co-investor Vertex Ventures HC 2018-09-06
Miracor–SEVERAL: investment, 201809 financing round Series D totalling €30m final closing led by Ming Capital (CN) 2018-09-04
Mologen–SEVERAL: investment, 201809 capital increase €8.2m with 1.73m new shares at €4.7/share to existing + new investors 2018-09-03
CHDI–Evotec: drug discovery services, 201808–2023 collab service extension CDHI funding up to 75 full-time scientists for Huntington’s disease drugs 2018-08-30
Lunaphore–SEVERAL: investment, 201808 financing round Series B CHF5.3m from existing + new investors 2018-08-30
Nebula Genomics–Heartbeat Labs: investment, 201808 seed financing round totalling $4.3m incl Heartbeat Labs 2018-08-29
Nebula Genomics–SEVERAL: investment, 201808 seed financing round $4.3m from ten leading tech + biotech VCs 2018-08-29
PhagoMed–Austria (govt): grant, 201808–2021 research project grant €3.5m from FFG 2018-08-28
PhagoMed–Austria (govt): investment, 201808 seed financing round totalling €1.55m incl €800k aws-Seedfinancing 2018-08-28
PhagoMed–SEVERAL: investment, 201808 seed financing round totalling €1.55m incl €750k from private investors 2018-08-28
PhagoMed–SEVERAL: investment, 201808 seed financing round €1.55m from private investors + aws 2018-08-28
Evotec–Centogene: drug discovery, 201808– collab ww strategic €na discovery + developm of treatments for rare genetic diseases 2018-08-27
Roche–Affimed: antibody cancer drug, 201808– collab $96m ufpront + $5b milestones + royalties using ROCK platform to develop ABs with Genentech 2018-08-27
Thermo Fisher–BioStrata: public relations, 201808 service existent by BioStrata 2018-08-27
Univ Wisconsin–Thermo Fisher: FAIMS technology, 201808 supply use of FAIMS device for shotgun proteomics by Joshua Coon 2018-08-27
Hain Lifescience–Bruker Corp: investment, 201808– acquisition €na of 80% majority interest with option to acquire rest in 2012 ANNOUNCED 2018-08-24
c-LEcta–Capricorn Venture Partners: investment, 201808 financing round incl new + lead investor Capricorn investing via CSCF NV + Quest for Growth 2018-08-23
c-LEcta–SEVERAL: investment, 201808 financing round €na with new investors Capricorn Venture Partners + bm|t 2018-08-23
c-LEcta–Thuringia (govt): investment, 201808 financing round incl new + co-investor bm|t via MFT Mittelstands-Fonds Thüringen 2018-08-23
Novaremed–SEVERAL: investment, 201804 financing round CHF4.44m to support phase 2b study of NRD.E1 in DNP 2018-08-23
Novaremed–SEVERAL: investment, 201808 financing round CHF6m to support phase 2b study of NRD.E1 in DNP 2018-08-23
Merck (DE)–GlucoMe: digital health, 201808– collab digital diabetes management project in Vietnam 2018-08-22
Novo Group–Evotec: drug discovery services, 201808– collab €na strategic alliance r+d small molecule drugs for diabetes + obesity Novo Nordisk 2018-08-22
SolasCure–BRAIN: investment, 201808 financing round Series A with participation of BRAIN at spin-off of SolasCure from BRAIN 2018-08-22
SolasCure–BRAIN: wound care product, 201808– license IP for Aurase enzyme + supply of enzymatic active ingredient by BRAIN to SolasCure 2018-08-22
SolasCure–SEVERAL: investment, 201808 financing round Series A with participation of BRAIN 2018-08-22
NuGen–Tecan: investment, 201808 acquisition $54.5m in cash by Tecan 2018-08-16
Oncologie–Mologen: lefitolimod, 201808–201811 term sheet for acquisition of ww rights to lefitolimod by Oncologie TERMINATED 11/18 2018-08-15
Bayer–Haplogen: antiviral agents, 201808– collab €na developm candidates for pulmonary diseases incl COPD 2018-08-14
Artios Pharma–AbbVie: investment, 201808 financing round Series B totalling $84m incl existing + co-investor AbbVie Ventures 2018-08-10
Artios Pharma–Andera Partners: investment, 201808 financing round Series B totalling $84m (£65m) incl new + lead investors Andera Partners + LSP 2018-08-10
Artios Pharma–Arix Bioscience: investment, 201808 financing round Series B totalling $84m incl existing + co-investor Arix Bioscience 2018-08-10
Artios Pharma–IP Group: investment, 201808 financing round Series B totalling $84m incl existing + co-investor IP Group 2018-08-10
Artios Pharma–Life Sciences Partners: investment, 201808 financing round Series B totalling $84m incl new + lead investors Andera Partners + LSP 2018-08-10
Artios Pharma–Merck (DE): investment, 201808 financing round Series B totalling $84m incl existing + co-investor M Ventures 2018-08-10
Artios Pharma–Novartis: investment, 201808 financing round Series B totalling $84m incl new + co-investor Novartis Venture Fund 2018-08-10
Artios Pharma–Pfizer: investment, 201808 financing round Series B totalling $84m incl new + co-investor Pfizer Ventures 2018-08-10
Artios Pharma–SEVERAL: investment, 201808 financing round Series B $84m (£65m) led by new investors Andera Partners + LSP 2018-08-10
Artios Pharma–SV Health Investors: investment, 201808 financing round Series B totalling $84m incl existing + co-investor SV 2018-08-10
Akouos–Novartis: investment, 201808 financing round Series A totalling $50m incl new co-investor Novartis Venture Fund 2018-08-07
Akouos–SEVERAL: investment, 201808 financing round Series A $50m co-led by existing investors 5AM Ventures + NEA 2018-08-07
United Kingdom (govt)–Bruker Corp: NMR technology, 201808 supply £20m NMR technology to 8 UK universities funded by EPSRC + BBSRC + MRC +NERC 2018-08-06
Univ Birmingham–Bruker Corp: NMR spectrometer, 201808 supply 1GHz NMR spectrometer 2018-08-06
Univ Warwick–Bruker Corp: NMR spectrometer, 201808 supply Avance 1.0 GHz solid-state NMR spectrometer 2018-08-06
Arsanis–Gates Foundation: grant, 201808 grant $1.1.m for preclinical development of ASN500 programme 2018-08-01
Miraca–Qiagen: molecular companion diagnostics, 201808– collab with SRL to introduce of CDx tests in Japan in line with respective drug approvals 2018-08-01
B&W Tek–Metrohm: investment, 201807 acquisition €na of B&W Tek LLC + several overseas subisidiaries 2018-07-27
Biocrates–MC Services: public relations, 201807 service existent by MC Services 2018-07-25
Nabriva–SEVERAL: investment, 201807 public offering $50m net $46.1m with 18.2m ordinary shares at $2.75/share 2018-07-25
Innovative Medicines Initiative–Agena Bioscience: MassARRAY Technology, 201807– collab use of MassArray system in CANCER-ID Consortium 2018-07-24
Zavante Therapeutics–Nabriva: investment, 201807 acquisition upfront 8.2m Nabriva ordinary shares (=19.9% shareholding) + $97.5m milestones 2018-07-24
SHS–SEVERAL: investment, 201807 first closing €90m of SHS V fund with target size of €150m 2018-07-20
Novartis–MorphoSys: therapeutic antibody, 201807– license excl ww to MOR106 from MOR+GLPG €95m upfront + €850m milestones + royalties + funding 2018-07-19
Adocia–MC Services: public relations, 201807 service existent PR Europe by MC Services 2018-07-18
Agilent–AMETEK: FTIR analyzer, 201807 collab developm + manufacturing Miniscan IR LOG FTIR analyzer for in-field oil/grease analysis 2018-07-18
Beiersdorf–S-Biomedic: skin microbiomics, 201807– collaboration 2018-07-18
DCPrime–Glycotope: cancer immunotherapy, 201807– license + collab agreement research new approaches to solid tumours 2018-07-18
S-Biomedic–Beiersdorf: investment, 201807 financing round Series A 1st closing totalling €2m incl lead investor Beiersdorf AG 2018-07-18
S-Biomedic–JnJ: investment, 201807 financing round Series A 1st closing totalling €2m incl co-investor JnJ Innovation JJDC 2018-07-18
S-Biomedic–SEVERAL: investment, 201807 financing round Series A 1st closing €2m led by Beiersdorf + incl investiere.ch + JnJ Innovation JJDC 2018-07-18
S-Biomedic–Verve Capital Partners: investment, 201807 financing round Series A 1st closing totalling €2m incl co-investor investiere.ch 2018-07-18
B Braun–CeGaT: personalised medicine, 201807 collab establishment of B Braun Precision Medicine Technology (Shanghai) Ltd 2018-07-17
CeGaT–B Braun: investment, 201807 existent 30% shareholding of B Braun in CeGaT 2018-07-17
Labfolder–NEC: information technology, 201807– collab €na combining Labfolder s/w with NEC hardware for scalable data storage solutions 2018-07-17
Polares Medical–Decheng Capital: investment, 201807 financing round totalling $25m incl lead investor Decheng Capital 2018-07-17
Polares Medical–Earlybird: investment, 201807 financing round totalling $25m incl co-investor Earlybird Venture Capital Berlin 2018-07-17
Polares Medical–Endeavour Vision: investment, 201807 financing round totalling $25m incl co-investor Endeavour Vision 2018-07-17
Polares Medical–IDO Investments: investment, 201807 financing round totalling $25m incl co-investor IDO Investments 2018-07-17
Polares Medical–SEVERAL: investment, 201807 financing round $25m led by Decheng Capital 2018-07-17
Polares Medical–Wellington Partners: investment, 201807 financing round totalling $25m incl co-investor Wellington Partners 2018-07-17
Roche–Shionogi: virostatic agent, 201807 license to baloxavir marboxil excl ww without JP + TW to Roche existent 2018-07-17
Holtzbrinck–Scott Partnership: public relations, 201807– supply service marcom for BioData 2018-07-16
Genmab–Immatics: cancer immunotherapy, 201807– researc collab + excl license to targets for biospecific I-O drugs $54m upfront + $550m milestones 2018-07-12
JPK Instruments–Bruker Corp: investment, 201807 acquisition €na of JPK by Bruker 2018-07-12
Miltenyi Biotec–Scienion: cell handling technology, 201807– collab co-marketing MACSQuant Tyto Cell Sorter with cellenONE X1 Cell Dispenser 2018-07-12
Forbion–SEVERAL: investment, 201807 first close €270m of Forbion IV fund 2018-07-11
BioNTech–Consilium: public relations, 201807 service existent international media relations + European IR by CSC 2018-07-10
BioNTech–Roivant: LNP technology, 201807– license excl to apply Genevant’s LNP delivery technology to 5 of BioNTech’s oncology programs 2018-07-10
BioNTech–Trophic Communications: public relations, 201807 service existent German media relations by Trophic 2018-07-10
BioNTech–Westwicke Partners: public relations, 201807 service existent US IR by Westwicke Partners 2018-07-10
Pionyr Immunotherapeutics–Minapharm: biopharma production, 201807– supply service cell line + process dev + prod of 2nd therap antibody by ProBioGen 2018-07-10
Roivant–BioNTech: mRNA therapeutics, 201807– collab strategic partnership to develop 5 products for rare disease with Genevant 2018-07-10
Boehringer–MabVax Therapeutics: antibody cancer drug, 201807 acquisition all rights to preclinical antibody program for solid tumours 2018-07-09
IMMUNOMONITOR project–Biomax: pharmacogenomics, 201807– collab partner in Eurostars project to develop validation treatm response to cancer vaccines 2018-07-05
IMMUNOMONITOR project–Enpicom: pharmacogenomics, 201807– collab partner in Eurostars project to develop validation treatm response to cancer vaccines 2018-07-05
IMMUNOMONITOR project–EU (govt): grant, 201807– Eurostars grant €2m to develop clin validation for treatm response to cancer vaccines 2018-07-05
IMMUNOMONITOR project–OSE Immunotherapeutics: pharmacogenomics, 201807– collab project partner develop validation treatm response cancer vaccines 2018-07-05
next pagenext page 1 2 3 4 5 ... 55 56 57  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top